These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2203852)

  • 41. 12(R)-hydroxyeicosatetraenoic acid, an endogenous corneal arachidonate metabolite, lowers intraocular pressure in rabbits.
    Masferrer JL; Dunn MW; Schwartzman ML
    Invest Ophthalmol Vis Sci; 1990 Mar; 31(3):535-9. PubMed ID: 2318592
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of systemic administration of 0.5% tropicamide on intraocular pressure, pupillary diameter, blood pressure, and heart rate in normal cats.
    Schmidt KS; Hacker DV; Kass PH; Barkhoodarian AL
    Vet Ophthalmol; 2006; 9(2):137-9. PubMed ID: 16497239
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of 5-methylurapidil, an alpha 1a-adrenergic antagonist and 5-hydroxytryptamine1a agonist, on aqueous humor dynamics in monkeys and rabbits.
    Wang RF; Lee PY; Mittag TW; Podos SM; Serle JB
    Curr Eye Res; 1997 Aug; 16(8):769-75. PubMed ID: 9255505
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An orally active inhibitor of renin.
    Pals DT; Thaisrivongs S; Lawson JA; Kati WM; Turner SR; DeGraaf GL; Harris DW; Johnson GA
    Hypertension; 1986 Dec; 8(12):1105-12. PubMed ID: 3539793
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of PF-04217329 a prodrug of a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucoma.
    Prasanna G; Carreiro S; Anderson S; Gukasyan H; Sartnurak S; Younis H; Gale D; Xiang C; Wells P; Dinh D; Almaden C; Fortner J; Toris C; Niesman M; Lafontaine J; Krauss A
    Exp Eye Res; 2011 Sep; 93(3):256-64. PubMed ID: 21376717
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Responses to converting enzyme and renin inhibition. Role of angiotensin II in humans.
    Fisher ND; Allan D; Kifor I; Gaboury CL; Williams GH; Moore TJ; Hollenberg NK
    Hypertension; 1994 Jan; 23(1):44-51. PubMed ID: 8282330
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nitrovasodilators as a new class of ocular hypotensive agents.
    Nathanson JA
    J Pharmacol Exp Ther; 1992 Mar; 260(3):956-65. PubMed ID: 1532035
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effects of topical prazosin on normal and elevated intraocular pressure and blood pressure in rabbits.
    Rowland JM; Potter DE
    Eur J Pharmacol; 1980 Jun; 64(4):361-3. PubMed ID: 7389829
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of SC-56525, a potent, orally active renin inhibitor, in salt-depleted and renal hypertensive dogs.
    McMahon EG; Yang PC; Babler MA; Bittner SE; Suleymanov OD; Cain-Janicki KJ; Bedell LJ; Hanson GJ; Cook CS
    Hypertension; 1995 Jul; 26(1):95-100. PubMed ID: 7607739
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Systemic effects resulting from topical ocular administration of SCH 33861, a novel ACE inhibitor ocular hypotensive agent.
    Watkins RW; Baum T; Tedesco RP; Pula K; Barnett A
    J Ocul Pharmacol; 1988; 4(2):93-100. PubMed ID: 3049862
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The influence of clonidine on intraocular pressure after topical application to the eyes of anesthetized cats.
    Innemee HC; Hermans AJ; van Zwieten PA
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1979 Nov; 212(1):19-27. PubMed ID: 317232
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Latrunculins' effects on intraocular pressure, aqueous humor flow, and corneal endothelium.
    Peterson JA; Tian B; McLaren JW; Hubbard WC; Geiger B; Kaufman PL
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1749-58. PubMed ID: 10845595
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [In vitro and in vivo inhibition of renin by a thiazolylalanyl cyclostatine derivative].
    Muneta S
    Nihon Jinzo Gakkai Shi; 1989 Aug; 31(8):865. PubMed ID: 2512401
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intramuscular injection of chlorpromazine decreases intraocular pressure by lowering systemic blood pressure.
    Liu JH; Dacus AC
    Curr Eye Res; 1989 Dec; 8(12):1315-21. PubMed ID: 2627799
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Topical 8-bromo-cyclic GMP lowers intraocular pressure in rabbits.
    Becker B
    Invest Ophthalmol Vis Sci; 1990 Aug; 31(8):1647-9. PubMed ID: 2167302
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Forskolin lowers intraocular pressure in rabbits, monkeys, and man.
    Caprioli J; Sears M
    Lancet; 1983 Apr; 1(8331):958-60. PubMed ID: 6132271
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics and cardiovascular effects of YM-21095, a novel renin inhibitor, in dogs and monkeys.
    Shibasaki M; Usui T; Inagaki O; Asano M; Takenaka T
    J Pharm Pharmacol; 1994 Jan; 46(1):68-72. PubMed ID: 8201530
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics, acid-base balance and intraocular pressure effects of ethyloxaloylazolamide--a novel topically active carbonic anhydrase inhibitor.
    Sharir M; Pierce WM; Chen D; Zimmerman TJ
    Exp Eye Res; 1994 Jan; 58(1):107-16. PubMed ID: 8157096
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effects of topical and general anesthesia on ocular drug levels and intraocular pressure lowering activity of topically applied carbonic anhydrase inhibitors.
    Bar-Ilan A; Pessah NI
    J Ocul Pharmacol; 1988; 4(1):1-12. PubMed ID: 3171330
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of MK-927, a topical carbonic anhydrase inhibitor, on IOP in glaucomatous monkeys.
    Wang RF; Serle JB; Podos SM; Surgrue MF
    Curr Eye Res; 1990 Feb; 9(2):163-8. PubMed ID: 2335112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.